ADCT
Price
$4.01
Change
+$0.10 (+2.56%)
Updated
Feb 6 closing price
Capitalization
496.75M
32 days until earnings call
Intraday BUY SELL Signals
OCUL
Price
$9.16
Change
+$0.25 (+2.81%)
Updated
Feb 6 closing price
Capitalization
2B
92 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs OCUL

Header iconADCT vs OCUL Comparison
Open Charts ADCT vs OCULBanner chart's image
ADC Therapeutics SA
Price$4.01
Change+$0.10 (+2.56%)
Volume$1.05M
Capitalization496.75M
Ocular Therapeutix
Price$9.16
Change+$0.25 (+2.81%)
Volume$4.1M
Capitalization2B
ADCT vs OCUL Comparison Chart in %
ADCT
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADCT vs. OCUL commentary
Feb 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 08, 2026
Stock price -- (ADCT: $4.01 vs. OCUL: $9.16)
Brand notoriety: ADCT and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 81% vs. OCUL: 86%
Market capitalization -- ADCT: $496.75M vs. OCUL: $2B
ADCT [@Biotechnology] is valued at $496.75M. OCUL’s [@Biotechnology] market capitalization is $2B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 3 bearish.
  • OCUL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than OCUL.

Price Growth

ADCT (@Biotechnology) experienced а +11.08% price change this week, while OCUL (@Biotechnology) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

OCUL is expected to report earnings on May 11, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2B) has a higher market cap than ADCT($497M). ADCT YTD gains are higher at: 13.598 vs. OCUL (-24.547). ADCT has higher annual earnings (EBITDA): -112.75M vs. OCUL (-233.54M). OCUL has more cash in the bank: 345M vs. ADCT (235M). OCUL has less debt than ADCT: OCUL (77M) vs ADCT (117M). ADCT has higher revenues than OCUL: ADCT (75.2M) vs OCUL (55.8M).
ADCTOCULADCT / OCUL
Capitalization497M2B25%
EBITDA-112.75M-233.54M48%
Gain YTD13.598-24.547-55%
P/E RatioN/AN/A-
Revenue75.2M55.8M135%
Total Cash235M345M68%
Total Debt117M77M152%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTOCUL
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
79%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
OCUL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBTGX39.420.92
+2.39%
Sterling Capital Behav Lg Cp Val Eq A
GSISX34.500.73
+2.16%
Goldman Sachs International Eq ESG Svc
SVUIX38.920.82
+2.15%
NAA SMid Cap Value Institutional
IIVGX23.150.43
+1.89%
Voya Growth and Income Port I
CCCRX38.010.69
+1.85%
Columbia Contrarian Core R

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+2.56%
QTTB - ADCT
43%
Loosely correlated
+9.56%
CLRB - ADCT
42%
Loosely correlated
+7.80%
RXRX - ADCT
40%
Loosely correlated
+11.80%
RGNX - ADCT
40%
Loosely correlated
+0.68%
OCUL - ADCT
38%
Loosely correlated
+2.81%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with AGIO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+2.81%
AGIO - OCUL
60%
Loosely correlated
-0.15%
LENZ - OCUL
58%
Loosely correlated
+1.79%
ACLX - OCUL
57%
Loosely correlated
+1.63%
LEGN - OCUL
55%
Loosely correlated
+2.40%
TPST - OCUL
55%
Loosely correlated
+7.62%
More